Evaluating the Efficacy of Artificial Intelligence-based Computer Aided Diagnosis Software That Assists in Determining Whether or Not to Conduct Amyloid PET for the Diagnosis of Alzheimer's Disease by Predicting Amyloid PET Positivity in Mild Cognitive Impairment Patients
Completed
- Conditions
- Alzheimer DiseaseMild Cognitive Impairment
- First Posted Date
- 2022-05-19
- Last Posted Date
- 2022-09-16
- Lead Sponsor
- Neurozen Inc.
- Target Recruit Count
- 227
- Registration Number
- NCT05383053
- Locations
- 🇰🇷
Chonnam National University Hospital, Gwangju, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath